Personalizing surgical margins in retroperitoneal sarcomas: an update
- 8 June 2019
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 19 (7) , 613-631
Abstract
Introduction: Tumor biology, as well as completeness of surgical resection, are two important prognostic factors when treating retroperitoneal sarcoma (RPS). A frontline extended surgical approach is associated with improved local control and possibly improved survival. However, this approach has to be tailored to each histological subtype, as the patterns of growth and recurrence risks vary significantly among them. Areas covered: We provide a review of the literature in RPS, describing the behavior of each of the five main histologic subtypes: well-differentiated liposarcoma (WDLPS), dedifferentiated liposarcoma (DDLPS), leiomyosarcoma (LMS), solitary fibrous tumor (SFT) and malignant peripheral nerve sheath tumor (MPNST). The prognostic factors relevant to oncologic outcomes of RPS, the role of margins and the importance of local control are discussed. Finally, a histologic specific surgical approach to RPS is provided in detail. Expert opinion: While tumor-related factors are paramount, the only intervenable predictive factor is extent and quality of surgery. The extended surgical approach has been advocated for previously and again we describe it in more detail, tailored specifically to the tumor subtype. The aim of this approach is to maximize the possibility of achieving a complete resection through a standardized approach based on histologic behavior and site of origin.Keywords
Funding Information
- not funded
This publication has 57 references indexed in Scilit:
- Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1Neuro-Oncology, 2012
- Technical Considerations in Surgery for Retroperitoneal Sarcomas: Position Paper from E-Surge, a Master Class in Sarcoma Surgery, and EORTC–STBSGAnnals of Surgical Oncology, 2012
- Retroperitoneal Sarcoma: Is It Time to Change the Surgical Policy?Annals of Surgical Oncology, 2011
- Contiguous organ resection is safe in patients with retroperitoneal sarcoma: An ACS‐NSQIP analysisJournal of Surgical Oncology, 2010
- Predictors of Survival After Resection of Retroperitoneal SarcomaAnnals of Surgery, 2009
- Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local ControlJournal of Clinical Oncology, 2009
- Malignant Peripheral Nerve Sheath TumorsNeurosurgery Clinics of North America, 2008
- The prognostic impact of dedifferentiation in retroperitoneal liposarcomaCancer, 2008
- Resectable Well-Differentiated versus Dedifferentiated Liposarcomas: Two Different Diseases Possibly Requiring Different Treatment ApproachesAnnals of Surgical Oncology, 2008
- Retroperitoneal sarcomas: Combined-modality treatment approachesJournal of Surgical Oncology, 2006